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Private hospitals in Japan appear to play an important role in the fertility preservation in cancer patients.
However, only a few university-related institutions have published their data about sperm banking. Here we
report our experience in a private hospital. The database of 5 years of experience with sperm
cryopreservation for male cancer patients was reviewed. We assessed the type of cancer, timing of
collection, sperm quality, and utilization for reproductive purposes. There were a total of 88 oncology
patients who underwent sperm banking at our institution during the study period. Types of cancer were
various, with testicular cancer and hematological malignancies comprising the largest groups. Nearly 90%
of the testicular cancer patients had their sperm preserved prior to the therapy, while only 53% of those with
hematological disease did so. Evaluation of semen parameters for these groups revealed that
oligozoospermia in testicular cancer patients, even prior to initiation of cancer therapy, was common. Five
patients utilized their specimens for reproductive purposes. Of these, 3 patients successfully fathered a child.
Our results suggest that sperm cryopreservation before initiation of cancer therapy in male oncology patients
is under-utilized. Additionally, there is minimal use of cryopreserved specimens for reproductive purposes.
This under-utilization is supposed to be due to physicians', especially hematologists', insufﬁcient awareness
toward chemotherapy-related infertility and the paucity of reports regarding reproductive outcome after
freezing. More data should be compiled to help both physicians and patients who are considering sperm
cryopreservation.
(Hinyokika Kiyo 55 : 9-13, 2009)
































































（更新制 :初回 6万円，以後更新ごとに 1万円 : 2001
年 7月∼2008年 7月）．
精液検査はWHOのガイドライン12)に基づいて行っ
た．凍結保存用の保存液は Sperm Freezing Medium
（ナカメディカル，東京）を使用し，液体窒素蒸気凍
結法を用いて凍結保存した．統計学的有意差の検定に








賀県 1施設 4人（ 5％）となっており，愛知県からも

















Fig. 1. Distribution of the hospitals the patients
came from, by prefecture.
泌55,01,03-2
Fig. 2. Number of cryopreservation per year in the
period 2001-2006. Hematologic : hemato-
logic malignancies, testis : testis cancer.














































Table 1. Underlying disease of the patients
Underlying Disease No. patients
Testis cancer 33 (37.5％)







Adult T-cell leukemia 1








Langerhans cell histiocytosis 1
Multiple sclerosis 1
Primary amyloidosis 1
Desmoplastic small round cell tumor 1
aPNET : primitive neuro ectodermal tumor.
Table 2. Comparison of sperm count according to the
underlying disease
Testis cancer Others p
Classiﬁcation 0.004
Normoa 16 (55％) 25 (89％)
Oligob 13 (45％) 3 (11％)
Sperm count (×106/ml) 33.7 53.6 0.066
anormo : normozoospermia, boligo : oligozoospermia
Table 3. Summary of utilization of cryopreserved sperm
No. Age Disease Prior CTxa Semen quality at presentation Storage period Mode of ART Birth
1 39 MLb No 63×106 f, 78％g 1 y AIH×4 Yes
2 31 TTc No 79×106, 48％ 4 y ICSI×2 Yes
3 30 TT No 101×106, 48％ 14 mo ICSI×1 Yes
4 29 ALLd Yes 9×106, 1％ 21 mo ICSI×1 No
5 29 BTe No 165×106, 65％ 4.5 y ICSI×5 No
aCTx : chemotherapy, bML : malignant lymphoma, cTT : testis tumor, dALL : acute lymphocytic leukemia, eBT : bladder tumor, f : sperm















































































1) Jenney M and Levitt G : The quality of survival after
childhood cancer. Eur J Cancer 38 : 1241-1250,
2002
2) Howell SJ and Shalet SM : Spermatogenesis after
cancer treatment : damage and recovery. J Natl
Cancer Inst Monogr 34 : 12-17, 2005
3) Aslam I, Fishel S, Moore H, et al. : Fertility
preservation of boys undergoing anti-cancer therapy : a
review of the existing situation and prospects for the
future. Hum Reprod 15 : 2154-2159, 2000
4) Lee SJ, Schover LR, Partridge AH, et al. : American
Society of Clinical Oncology recommendations on
fertility preservation in cancer patients. J Clin Oncol









泌尿紀要 55巻 1号 2009年12
8) 西山博之，宗田 武，市岡健太郎，ほか :長期精
子凍結保存の実施状況に関する全国アンケート調
査．泌尿紀要 54 : 593-598，2008
9) 齋藤和男，鈴木康太郎，野口和美，ほか :精子凍
結保存10年間の経験 :その現状と問題点．日泌尿




11) Ishikawa H, Kaneko S, Miyaji K, et al. :
Cryopreservation of human sperm in patients with
malignancy : ﬁrst 2 years' experience. Reprod Med
Biol 6 : 127-131, 2007
12) World Health Organization : WHO laboratory
manual for the examination of human semen and
sperm-cervical mucus interaction. 4th ed. Cam-
bridge University Press, Cambridge, UK, 1999
13) 渡邊知映，高橋 都，甲斐一郎 :化学療法に伴う
性腺機能障害への血液内科医の意識と情報提供の
実態調査．癌と化療 34 : 891-896，2007
14) Saito K, Suzuki K, Iwasaki A, et al. : Sperm
cryopreservation before cancer chemotherapy helps in
the emotional battle against cancer. Cancer 104 :
521-524, 2005
15) Thewes B, Meiser B, Rickard J, et al. : The fertility-
and menopause-related information needs of younger
women with a diagnosis of breast cancer : a qualitative
study. Psychooncol 12 : 500-511, 2003
16) Skakkebaek NE, Rajpert-De Meyts E and Main KM :
Testicular dysgenesis syndrome : an increasingly
common developmental disorder with environmental
aspects. Hum Reprod 16 : 972-978, 2001
17) Magelssen H, Brydoy M and Fossa SD : The effects of
cancer and cancer treatments on male reproductive
function. Nat Clin Pract Urol 3 : 312-322, 2006
(Accepted on September 22, 2008)
Received on July 22, 2008
宗田，ほか :長期精子凍結保存・悪性腫瘍 13
